AstraZeneca sets out $15 billion China investment during Starmer visit

January 29, 2026

UK drugmaker AstraZeneca said on Thursday it would invest $15 billion in China through 2030 to expand medicines manufacturing and research and development, an announcement made during British Prime Minister Keir Starmer’s visit to Beijing.

Search

RECENT PRESS RELEASES

Scaling content review operations with multi-agent workflow

SWI Editorial Staff2026-01-29T18:22:52-08:00January 29, 2026|

Scaling content review operations with multi-agent workflow

SWI Editorial Staff2026-01-29T18:22:19-08:00January 29, 2026|

Build a trusted foundation for data and AI using Alation and Amazon SageMaker Unified Stud

SWI Editorial Staff2026-01-29T18:22:11-08:00January 29, 2026|

Futures: Apple Rises, Sandisk Soars After Stocks Rebound

SWI Editorial Staff2026-01-29T18:21:10-08:00January 29, 2026|

Build a trusted foundation for data and AI using Alation and Amazon SageMaker Unified Stud

SWI Editorial Staff2026-01-29T18:20:55-08:00January 29, 2026|

Crypto Bros in Meltdown as Bitcoin Crashes

SWI Editorial Staff2026-01-29T18:19:03-08:00January 29, 2026|